Literature DB >> 34306491

The effects of systematic psychological nursing on the sleep quality of schizophrenic patients with sleep disorders.

Manru Li1, Bibo Lang2.   

Abstract

OBJECTIVE: This study was designed to explore the effects of systematic psychological nursing (SPN) on the sleep quality of schizophrenic patients with sleep disorders.
METHODS: A total of 101 schizophrenic patients with sleep disorders were divided into the control group (50 patients who underwent routine nursing) and the observation group (51 patients who underwent SPN, including health education, psychological nursing, cognitive intervention, reasonable entertainment, and family and social support). One month after the nursing, the sleep quality (the Pittsburgh Sleep Quality Index (PSQI) scores), the improvement in the patients' schizophrenic symptoms (their Positive and Negative Syndrome Scale (PANSS) scores), their sense of self-esteem (their Self-Esteem Scale (SES) scores), their medication compliance (their Morisky Medication Adherence Scale (MMAS) scores), their self-efficacy (their Strategies Used by People to Promote Health (SUPPH) scores), and their quality of life (Generic Quality of Life Inventory (GQOLI)-74 scores) were compared between the two groups.
RESULTS: After the nursing, the PSQI and PANSS scores in the two groups were decreased, and lower scores were seen in the observation group (both P<0.05). However, there were opposite trends in the SES, MMAS, GQOLI-74, and SUPPH scores (all P<0.05).
CONCLUSION: SPN can effectively improve the schizophrenia symptoms and the sleep quality, enhance the sense of self-esteem, and improve the medication compliance, self-efficacy, and quality of life in schizophrenic patients with sleep disorders. Therefore, SPN is worthy of clinical application. AJTR
Copyright © 2021.

Entities:  

Keywords:  Schizophrenia; quality of life; sleep disorders; systemic psychological nursing

Year:  2021        PMID: 34306491      PMCID: PMC8290645     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

Review 1.  Cancer in patients with schizophrenia: What is the next step?

Authors:  Frank H-C Chou; Kuan-Yi Tsai; Hung-Chi Wu; Shih-Pei Shen
Journal:  Psychiatry Clin Neurosci       Date:  2016-08-14       Impact factor: 5.188

2.  Exploratory factor analysis: strategies used by patients to promote health.

Authors:  Elise L Lev; Lucille Sanzero Eller; John Kolassa; Glen Gejerman; Joan Colella; Patricia Lane; Suzanne Scrofine; Michael Esposito; Vincent Lanteri; John Scheuch; Ravi Munver; Bernadette Galli; Richard A Watson; Ihor Sawczuk
Journal:  World J Urol       Date:  2007-03       Impact factor: 4.226

Review 3.  [Empathy in psychiatry and psychotherapy].

Authors:  G Esagian; S Esagian-Pouftsis; S G Kaprinis
Journal:  Psychiatriki       Date:  2019 Apr-Jun

Review 4.  Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention.

Authors:  Sooyeon Suh; Nayoung Cho; Jihui Zhang
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

5.  Sleep disturbance and quality of life in clinically stable inpatients with schizophrenia in rural China.

Authors:  Wei-Liang Wang; Yu-Qiu Zhou; Nan-Nan Chai; Guo-Hua Li
Journal:  Qual Life Res       Date:  2020-05-25       Impact factor: 4.147

Review 6.  Sleep, circadian rhythms, and schizophrenia: where we are and where we need to go.

Authors:  Jan Cosgrave; Katharina Wulff; Philip Gehrman
Journal:  Curr Opin Psychiatry       Date:  2018-05       Impact factor: 4.741

7.  Evaluation of Inappropriate Medication Use and Compliance in Elderly People.

Authors:  Fikriye Yilmaz; Meric Yavuz Colak
Journal:  Curr Drug Saf       Date:  2018

8.  Controlled trial of the effectiveness of community rehabilitation for patients with schizophrenia in Shanghai, China.

Authors:  Ying Zhou; Rongshan Zhou; Wenjie Li; Yiqiang Lin; Jian Yao; Jian Chen; Tao Shen
Journal:  Shanghai Arch Psychiatry       Date:  2015-06-25

9.  Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia.

Authors:  Yuan Feng; Jianguo Shi; Lili Wang; Xia Zhang; Yunlong Tan; Jingyuan Zhao; Yuping Ning; Shiping Xie; Xuejun Liu; Qi Liu; Keqing Li; Xiaoliang Wang; Lehua Li; Xiufeng Xu; Wei Deng; Xiaoyan Luo; Gang Wang
Journal:  Psychiatry Clin Neurosci       Date:  2020-01-08       Impact factor: 5.188

Review 10.  Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia.

Authors:  Claudio Brasso; Silvio Bellino; Paola Bozzatello; Cristiana Montemagni; Paola Rocca
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.